The analysis revealed consistent gastrointestinal-related adverse events across all weight groups, including nausea, vomiting, decreased appetite, and weight loss
In another study, liraglutide was shown to prevent the onset of endoplasmic reticulum stress in HUVECs exposed to high glucose via dose dependent induction of mitochondrial fusion marker, OPA1, thereby inhibiting mitochondrial fragmentation and apoptosis [104]
Consult your healthcare professional for personalized recommendations.
Their medical professionals carefully assess each patients health history, current medications, and specific weight-related challenges before creating a personalized treatment plan
2B, Supplemental Table 2)
Others with hyperemesis require repeated ambulatory treatment or hospital care